BackEdwards Lifesciences Overview

Edwards Lifesciences Current Cash

Track Edwards Lifesciences's current cash ($2.9B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.91B
↓ 11.19% YoYΔ $-366.30M vs prior year quarter

Peer trimmed avg / median

Loading

Edwards Lifesciences Current Cash History

Loading

Edwards Lifesciences vs. peers: Current Cash Comparison

Loading

Edwards Lifesciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Edwards Lifesciences (EW) FAQ

As of the most recent data (June 2026), EW shows a current cash of $2.9B. That compares with $3.3B in the prior-year period — down 11.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EW's current cash is now $2.9B (was $3.3B) — a 11.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Edwards Lifesciences is outperforming or lagging.

Tracking EW's current cash over time shows whether Edwards Lifesciences is scaling, shrinking, or reshaping that part of the business. The current reading is $2.9B That compares with $3.3B in the prior-year period — down 11.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Edwards Lifesciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $2.9B) with ownership activity and broader fundamentals.

Edwards Lifesciences's current cash is $2.9B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.